Attitudes to chemotherapy in patients with ovarian cancer

Penson, Richard T.; Dignan, Fiona L.; Seiden, Michael V.; Lee, H.; Gallagher, Chris; Matulonis, Ursula A.; Olson, Karin; Gibbens, I.; Gore, Martin

doi:10.1016/j.ygyno.2004.05.034

Cited by 29 publications

(18 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sample sizes in previous studies that have investigated patient attitudes towards advanced cancer treatment have been much smaller and included patients from only one or two countries [13][14][15][16][17][18][19][20][21][22]. Moreover, in our study, the patient attitude was determined specific to their disease condition unlike most of the previous studies where hypothetical scenarios were used [14][15][16][18][19][20][21][22].…”

Section: Discussionmentioning

confidence: 99%

“…Perez [23] found that a significant proportion of physicians recommend only supportive care for patients with stage IV NSCLC, despite the demonstrated benefits of chemotherapy. Furthermore, in studies of patients with colon cancer [21] and ovarian cancer [22], where the prognosis could be expected to be better than that for Stage III/IV NSCLC, it was found that patient preferences were not always aligned with those of clinicians. Differences between patient and physician attitudes in the present study can be partly ascribed to the fact that each has a different outlook towards disease.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer

Chu¹,

Kim

Kuo

et al. 2007

Lung Cancer

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer

Chu¹,

Kim

Kuo

et al. 2007

Lung Cancer

View full text Add to dashboard Cite

“…Some of the women may have not considered "doing nothing" or best supportive care as an option. In prior studies, women have also failed to perceive best supportive care as an option, or felt it would be applicable a low percentage of the time (Charles, Redko, Whelan, Gafni & Reyno, 1998;Penson et al, 2004). Women may also have not perceived they had options due to poor recall of their conversation with the physician.…”

Section: Perception Of the Decisionmentioning

confidence: 99%

“…Secondly, these studies directly measured decisional conflict using the Decisional Conflict Scale; while women in this study qualitatively described how they felt at the time they made the decision. Finally, the low report of difficulty in making the decision may well be attributed to the high level of acceptance of chemotherapy by women with ovarian cancer (Donovan, Greene, Shuster, Partridge & Tucker, 2002;Penson et al, 2004).…”

Section: Perception Of the Decisionmentioning

confidence: 99%

Women’s decision-making needs related to treatment for recurrent ovarian cancer: A pilot study

Jolicoeur

O’Connor²,

Hopkins³

et al. 2009

CONJ

View full text Add to dashboard Cite

The purpose of this pilot study was to describe the decision-making needs of women with ovarian cancer related to treatment of recurrent disease.Design: A retrospective, cross-sectional needs assessment was conducted. Data were collected using face-to-face interviews and analyzed using content analysis. Group, 2006). Given the lack of one superior treatment, decisions should be based on patient preferences (O'Connor et al., 2004). ResultsThere is evidence that women want more information related to ovarian cancer (Stewart et al., 2000). In one qualitative study, women reported not feeling knowledgeable enough to participate in decisions about primary treatment . However, they felt better prepared to participate at the time of recurrence . A decision aid may be able to address women's informational needs related to treatment options. However, it is not clear what information women with ovarian cancer value (find important to consider) in making treatment-related decisions (Fitch, Gray, DePetrillo, Franssen & Howell, 1999;Stewart et al., 2000). Only one study has reported on the types of resources and decision support interventions women with ovarian cancer prefer (Stewart et al., 2000). However, research findings show that more than half of women with ovarian cancer want to play an active role in decision-making Stewart et al., 2000). Thus far, it is not clear what role women with ovarian cancer have actually had in decision-making (Elit et al., 2003;Fitch et al., 2003;Howell et al., 2003). PurposeThe purpose of this pilot study was to describe the decision-making needs of women with ovarian cancer related to treatment of recurrent disease. The Ottawa Decision Support Framework (ODSF) (O'Connor & Jacobsen, 2007) was the conceptual framework guiding the study. The ODSF is divided into three components or processes: (1) assessing needs, which are the determinants of decisions that may be suboptimal and lead to poor decision-making; (2) providing decision support that is tailored to the needs, and (3) evaluating the decision-making process and the outcomes of the decision ( Figure One). MethodologyA pilot study was conducted in order to test the recruitment process and the interview tool. We used a retrospective cross-sectional design to describe the needs of women who had made a treatment decision and it was based on needs assessment principles (Witkin & Altschuld, 1995 Women's decision-making needs related to treatment for recurrent ovarian cancer: A pilot study Lynne J.A. Jolicoeur, RN, MScN, CON(C)

show abstract

“…52 Unfortunately, sexual dysfunction is a subject that may not be discussed for several reasons, including a patient's hesitation to initiate a conversation about a sensitive topic with her physician, a patient's own belief that she should focus discussion on treatment-related issues, time constraints during a clinic appointment and a physician's own reluctance to discuss the topic. 53,54 Loss of fertility In addition to physical symptoms associated with surgically-induced menopause, loss of fertility can be devastating for younger women diagnosed with ovarian cancer, and this consequence of treatment can be more difficult to accept than the original diagnosis of cancer. This is particularly true for women who have not yet begun or completed childbearing, and this problem, combined with a new cancer diagnosis, may be emotionally overwhelming for patients.…”

Section: Sexual Dysfunctionmentioning

confidence: 99%

Quality of life for patients with epithelial ovarian cancer

2007

View full text Add to dashboard Cite

Ovarian cancer is the sixth most common cancer worldwide and the seventh most common cause of deaths from cancer in women. Recent annual worldwide figures reflect 204,000 new cases of ovarian cancer and 125,000 deaths. Treatment of advanced ovarian cancer involves a combination of surgery and chemotherapy, both of which may impact a woman's physical, social, and emotional well-being. A woman's quality of life (QOL) is affected by disease site, and treatment-specific and patient-specific factors, but other common QOL issues include changes in physical functioning owing to side effects of treatment, psychological distress caused by fear and anxiety of recurrence, sexual dysfunction associated with anatomic and physiologic changes of treatment, and for younger women, loss of childbearing potential. As new diagnostic and treatment strategies for gynecologic malignancies are developed, research efforts should include QOL consequences. Further studies are needed to develop strategies for identifying women at risk for serious QOL disruption so that effective interventions to assist these women can be designed.

show abstract

Attitudes to chemotherapy in patients with ovarian cancer

Cited by 29 publications

References 24 publications

Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer

Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer

Women’s decision-making needs related to treatment for recurrent ovarian cancer: A pilot study

Quality of life for patients with epithelial ovarian cancer

Contact Info

Product

Resources

About